Gene therapy restores immune function to infants with SCID-X1 (X-linked severe combined immunodeficiency)

IL2RG protein, encoded by tL2RG complementary DNA. (https://commons.wikimedia.org/wiki/File:Protein_IL2RG_PDB_2b5i.png) As reported in the 18 April issue of the New England Journal of Medicine, researchers at the St. Jude Children’s Research Hospital (Memphis, TN) and their colleagues have used gene therapy to restore immune function to eight infants with newly diagnosed X-linked severe combined immunodeficiency [...]

The post Gene therapy restores immune function to infants with SCID-X1 (X-linked severe combined immunodeficiency) appeared first on Haberman Associates.